Breakthrough Data from Targeted Oncology Trials
The clinical pipeline for antibody-drug conjugates and bispecific antibodies is increasingly defined by the pursuit of validated and novel antigens across solid and hematological malignancies. Recent Targeted Oncology Trials have…